<code id='9507C09817'></code><style id='9507C09817'></style>
    • <acronym id='9507C09817'></acronym>
      <center id='9507C09817'><center id='9507C09817'><tfoot id='9507C09817'></tfoot></center><abbr id='9507C09817'><dir id='9507C09817'><tfoot id='9507C09817'></tfoot><noframes id='9507C09817'>

    • <optgroup id='9507C09817'><strike id='9507C09817'><sup id='9507C09817'></sup></strike><code id='9507C09817'></code></optgroup>
        1. <b id='9507C09817'><label id='9507C09817'><select id='9507C09817'><dt id='9507C09817'><span id='9507C09817'></span></dt></select></label></b><u id='9507C09817'></u>
          <i id='9507C09817'><strike id='9507C09817'><tt id='9507C09817'><pre id='9507C09817'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:42468
          Silhouetted hands passing money. -- health business coverage from STAT
          Adobe

          The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

          The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

          advertisement

          “Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          BIO: Crackdown on China pharma industry would threaten U.S. drug supply
          BIO: Crackdown on China pharma industry would threaten U.S. drug supply

          AdobeU.S.legislationthatwouldsevertieswithChinesedrugmakerswouldjeopardizethedrugsupplyformillionsof

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Meta looks to target Twitter with a rival app called Threads

          Theannouncementofthesocialmediaapp'Threads'isdisplayedinApple'sUSAppStoreseenonthescreenofasmartphon